A clinical trial to evaluate the efficacy of yoga based lifestyle program on women with poly cycstic ovarian syndrome

Efficacy of a yoga based lifestyle program on poly cystic ovarian syndrome. A randomized control trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2008/091/000291

Enrollment

100

Registered

2010-01-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Yoga Based Lifestyle Program: One Hour Per Day for Seven Days a week for three months Control Intervention1: Exercise Based Lifestyle Program: One hour a day for seven days a week for t

Eligibility

Inclusion criteria

Inclusion criteria: diagnosed with poly cystic ovarian syndrome according to Rotterdam criteria. participants should not have practiced yoga previously; not on any hormonal medication since the last six months.

Exclusion criteria

Exclusion criteria: tobacco and alcohol users; Rotterdam exclusion criteria, BMI less than 18 kg/m2

Design outcomes

Primary

Measure	Time frame
Body Mass IndexTimepoint: before and after 3 months;menstrual frequencyTimepoint: before and after 3 months;Perceived Stress ScaleTimepoint: before and after 3 months;Pol Cystic Ovary Syndrome Quality of Life questionnaireTimepoint: before and after 3 months;Positive Affect Negative Affect ScaleTimepoint: before and after 3 months;State and Trait Anxiety Inventory X1 and X2Timepoint: before and after 3 months;transvaginal ultrasound scanTimepoint: before and after 3 months;Waist Hip RatioTimepoint: before and after 3 months	—

Measure

Time frame

Body Mass IndexTimepoint: before and after 3 months;menstrual frequencyTimepoint: before and after 3 months;Perceived Stress ScaleTimepoint: before and after 3 months;Pol Cystic Ovary Syndrome Quality of Life questionnaireTimepoint: before and after 3 months;Positive Affect Negative Affect ScaleTimepoint: before and after 3 months;State and Trait Anxiety Inventory X1 and X2Timepoint: before and after 3 months;transvaginal ultrasound scanTimepoint: before and after 3 months;Waist Hip RatioTimepoint: before and after 3 months

—

Secondary

Measure	Time frame
Acne Rating ScaleTimepoint: before and after 3 months;Alopecia rating scaleTimepoint: before and after 3 months;Anti Mullerian FactorTimepoint: before and after 3 months;Fasting Blood SugarTimepoint: before and after 3 months;Fasting InsulinTimepoint: before and after 3 months;Hirsutism Rating ScaleTimepoint: before and after 3 months;Leutinizing Hormone vs Follicle Stimulating Hormone ratioTimepoint: before and after 3 months;Lipid Profile (Total Cholesterol, Triglycerides, HDL, LDL, VLDL, Total Cholesterol/HDL ratio)Timepoint: before and after 3 months;Serum TestosteroneTimepoint: before and after 3 months	—

Measure

Time frame

Acne Rating ScaleTimepoint: before and after 3 months;Alopecia rating scaleTimepoint: before and after 3 months;Anti Mullerian FactorTimepoint: before and after 3 months;Fasting Blood SugarTimepoint: before and after 3 months;Fasting InsulinTimepoint: before and after 3 months;Hirsutism Rating ScaleTimepoint: before and after 3 months;Leutinizing Hormone vs Follicle Stimulating Hormone ratioTimepoint: before and after 3 months;Lipid Profile (Total Cholesterol, Triglycerides, HDL, LDL, VLDL, Total Cholesterol/HDL ratio)Timepoint: before and after 3 months;Serum TestosteroneTimepoint: before and after 3 months

—

Countries

India

Contacts

Public ContactNidhi Choudhary

amritram@gmail.com08026612669

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026